Herbild L - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Does pharmacogenetic testing for CYP450 2D6 and 2C19 among patients with diagnoses within the schizophrenic spectrum reduce treatment costs?

Herbild L, Andersen SE, Werge T, Rasmussen HB, Jürgens G. Herbild L, et al. Basic Clin Pharmacol Toxicol. 2013 Oct;113(4):266-72. doi: 10.1111/bcpt.12093. Epub 2013 Jul 6. Basic Clin Pharmacol Toxicol. 2013. PMID: 23731498 Free article. Clinical Trial.

Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services?

Herbild L, Bech M, Gyrd-Hansen D, Christensen M, Werge T, Nielsen KA. Herbild L, et al. Scand J Public Health. 2011 Mar;39(2):147-55. doi: 10.1177/1403494810393300. Epub 2011 Jan 21. Scand J Public Health. 2011. PMID: 21257648

Patient preferences for pharmacogenetic screening in depression.

Herbild L, Gyrd-Hansen D, Bech M. Herbild L, et al. Int J Technol Assess Health Care. 2008 Winter;24(1):96-103. doi: 10.1017/S0266462307080129. Int J Technol Assess Health Care. 2008. PMID: 18218174

Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression.

Herbild L, Bech M, Gyrd-Hansen D. Herbild L, et al. Value Health. 2009 Jun;12(4):560-7. doi: 10.1111/j.1524-4733.2008.00465.x. Epub 2008 Oct 9. Value Health. 2009. PMID: 18980634 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters